Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00888745 · ClinicalTrials.gov registry record · Phase 1
A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis
A Phase 1 study, sponsored by Genentech.
- Completed
- Registry status
- Phase 1
- Development phase
- 65
- Enrollment target
NCT00888745 is a Phase 1 study that has completed, run by Genentech. The registered enrollment target is 65 participants.
The verdict
NCT00888745, a Phase 1 study, has completed, sponsored by Genentech.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 65 participants
- Enrollment target
Study Summary
This is a Phase I multicenter study that will be conducted in the United States and Europe.
Interventions
- DRUG placebo
- DRUG PRO283698
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2009-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00888745
The ClinicalTrials.gov registry entry for NCT00888745 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Genentech, which has 332 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00888745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00888745 about?
NCT00888745 is a clinical study titled "A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis". This is a Phase I multicenter study that will be conducted in the United States and Europe.
What is the current status of trial NCT00888745?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 65 participants. The study started on 2009-05.
What interventions are being tested in trial NCT00888745?
The interventions under investigation include: placebo (DRUG), PRO283698 (DRUG).
Who is sponsoring clinical trial NCT00888745?
This trial is sponsored by Genentech, which has 332 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.